Leukeran (Chlorambucil) – Patient Information Guide (UK)
Leukeran is a cancer medicine containing chlorambucil. It belongs to a group of medicines called alkylating agents. Leukeran is used in specific blood cancers and related conditions, usually under the care of specialist oncology teams.
This guide explains how Leukeran works, typical uses, how it is taken, key safety information, food and alcohol considerations, and practical tips for everyday use. It also includes information relevant to the United Kingdom, including availability and recent safety expectations.
1. Basic product information
| Feature | Details |
|---|---|
| Medicine name | Leukeran |
| Active ingredient | Chlorambucil |
| Medicine type | Chemotherapy (alkylating agent) |
| Common form | Tablets (oral use) |
| Who it is for | Selected adults (and in some cases specific specialist-led regimens for younger patients) with certain blood cancers |
| Typical monitoring | Regular blood tests (full blood count), infection risk checks, kidney/liver review as needed |
| Important caution | Can cause significant bone marrow suppression and long-term blood changes |
2. How Leukeran works (mechanism of action)
Chlorambucil works by damaging the genetic material inside cancer cells.
- Alkylation of DNA: Chlorambucil adds chemical groups to DNA, interfering with its ability to replicate.
- Cell-cycle disruption: When cancer cells cannot divide normally, growth slows and cell death may occur.
- Why it helps in blood cancers: Many blood cancers rely on rapidly dividing abnormal cells. Alkylating agents can be effective at reducing tumour burden.
Because chlorambucil also affects rapidly dividing healthy cells (especially bone marrow), it can lead to low blood cell counts, which is why monitoring is essential.
3. Pharmacokinetics (how the body processes it)
Pharmacokinetics describe how the body absorbs, distributes, breaks down, and eliminates the medicine.
- Absorption: As an oral tablet, chlorambucil is absorbed from the gastrointestinal tract.
- Distribution: It distributes throughout the body, reaching tissues where it can affect cancer cells.
- Metabolism: Chlorambucil is metabolised (broken down) mainly in the body, producing active forms that contribute to its effect.
- Elimination: Metabolites are cleared from the body primarily through renal (kidney) pathways, with some contribution from other routes.
Clinical implication: Your specialist may adjust or monitor treatment more closely if you have kidney or liver problems, or if you are taking other medicines that could interact.
4. Typical use and treatment approach
Leukeran is used for certain haematological (blood) malignancies and related conditions. It may be used in:
- Chronic lymphocytic leukaemia (CLL): Particularly where the cancer is not controlled by other approaches, or where a specialist-led regimen includes chlorambucil.
- Some other lymphoid disorders: Including cases where an alkylating agent is considered appropriate based on disease features and patient factors.
In many modern CLL pathways, newer targeted therapies (such as BTK inhibitors or BCL-2 inhibitors) may be preferred depending on stage, genetics, age, co-morbidities, and local guidance. However, chlorambucil may still be considered in specific circumstances or alternative regimens.
5. When and how to take Leukeran (timing)
How you take Leukeran depends on the prescribed regimen. Because dosing may differ between conditions and patient groups, always follow the exact schedule given by your clinical team.
General timing considerations:
- Try to take at the same time each day if your regimen is daily.
- Use a consistent routine: Many people find it helpful to take tablets at the same time with water, often after a meal to reduce stomach upset (see food section).
- If you miss a dose: Do not double up. Contact your healthcare team for advice on what to do next.
Storage and handling: Keep tablets in their original packaging, out of the reach of children. Healthcare professionals may advise special handling precautions due to the nature of chemotherapy medicines.
6. Food interactions and dietary considerations
Leukeran can typically be taken with or without food, but individual tolerance may vary.
- Stomach comfort: If you experience nausea or stomach irritation, taking your dose with food or after a light meal may help.
- Grapefruit and herbal supplements: There is no single “must-avoid” food listed for everyone, but herbal products (including St John’s Wort) and high-dose supplements can affect chemotherapy metabolism and safety.
- Hydration: Drink fluids as advised by your clinical team, especially if you are prone to dehydration or unwell with infections.
Tip: Keep a simple food and side-effect diary for the first few cycles. This can help you and your team identify triggers such as nausea or diarrhoea.
7. Alcohol and medicine interactions
Alcohol may worsen some side effects of chemotherapy (such as tiredness, nausea, appetite changes, and liver stress). It may also increase infection risk indirectly by affecting sleep and recovery.
- Avoid heavy drinking: If you drink at all, keep it moderate and discuss with your oncology team.
- Do not use alcohol to “treat” side effects: For example, avoid alcohol as a way to manage nausea or insomnia.
- Medication interactions: Tell your clinician about all medicines you take, including:
- Over-the-counter painkillers
- Antibiotics
- Antifungals
- Antivirals
- Herbal remedies and supplements
Important note: The most significant safety issue with chlorambucil is its effect on the bone marrow (low blood cells). Medicines that further suppress the immune system or affect blood counts should be discussed with your team.
8. Indications (what Leukeran is used for)
Indications can vary by patient characteristics and local practice. In the UK, chlorambucil-containing regimens are generally used for selected haematological cancers.
- Chronic lymphocytic leukaemia (CLL): Particularly where an alkylating agent is suitable for the clinical scenario.
- Other lymphoid malignancies: In specialist-led treatment plans where chlorambucil is considered beneficial.
Your healthcare team will decide whether Leukeran is appropriate based on disease stage, prior treatments, blood counts, genetic markers, your overall health, and alternative options.
9. Dosing (general information)
Dosing for Leukeran is individualised and depends on factors such as diagnosis, treatment schedule, blood test results, and tolerability.
- Tablet strength: Leukeran tablets come in specific strengths. Your dose will be calculated by your clinician in milligrams (mg) per day or per schedule.
- Cycles and pauses: Many chemotherapy regimens include cycles with monitoring and possible dose adjustments.
- Blood-count guided adjustments: Because chlorambucil can reduce white blood cells, platelets, and haemoglobin, doctors may delay doses or reduce the dose if counts fall too far.
- Duration: The course length depends on response and side effects.
What to expect during treatment: Regular blood tests (often weekly or every few weeks early on, depending on protocol) help balance effectiveness with safety.
Do not self-adjust: Only your oncology team should change dosing.
10. Safety profile and key risks
Like other chemotherapy medicines, Leukeran can cause side effects. Not everyone will experience all side effects, and many can be managed with supportive care. The most important risks relate to bone marrow suppression.
10.1 Bone marrow suppression (low blood counts)
- Neutropenia: Low white blood cells increases infection risk.
- Thrombocytopenia: Low platelets increases bleeding risk (bruising, nosebleeds, bleeding gums).
- Anaemia: Low red blood cells can cause tiredness, breathlessness, and weakness.
When to seek urgent medical help:
- High temperature or fever (especially if your blood counts are low)
- Severe sore throat, mouth ulcers, or signs of serious infection
- Unusual bleeding, black stools, or severe bruising
- New severe shortness of breath or chest pain
10.2 Increased risk of infections
If your immune system is suppressed, infections can become serious quickly. Preventive measures may include vaccinations (timed appropriately), monitoring, and prompt treatment of infections.
10.3 Gastrointestinal effects
- Nausea
- Vomiting
- Diarrhoea or constipation
- Loss of appetite
10.4 Fatigue and general effects
Many people experience tiredness during chemotherapy. Rest is important, but so is gentle activity as tolerated. If fatigue becomes severe or sudden, inform your clinical team.
10.5 Potential long-term risks
Chemotherapy can, in some circumstances, be associated with longer-term effects including effects on blood formation and, rarely, secondary malignancies. Your specialist will weigh the potential benefits against risks based on your health and prognosis.
10.6 Allergy and hypersensitivity (rare)
Seek medical advice urgently if you develop signs of allergy such as swelling of the face/lips, rash with breathing difficulties, or severe skin reactions.
11. Practical use tips (day-to-day guidance)
- Keep a medicines list: Include all prescriptions, over-the-counter medicines, supplements, and herbal products.
- Attend blood test appointments: Even if you feel well, blood counts can drop before symptoms appear.
- Infection prevention: Follow advice on hand hygiene, avoiding close contact with people who are unwell, and seeking prompt help for fever.
- Bleeding precautions: Use a soft toothbrush if platelet counts are low; avoid activities that increase bleeding risk unless your team says it’s safe.
- Skin care: Use gentle skin products and keep hydrated if you experience dryness or irritation.
- Track side effects: Note timing, severity, and anything that helps. This helps clinicians adjust supportive medicines.
- Pregnancy prevention: If relevant, use effective contraception and discuss pregnancy planning with your clinical team before starting treatment. (See also fertility and contraception section below.)
Fertility and contraception
Chlorambucil may affect fertility. It can also harm an unborn baby. Your clinical team will advise on contraception for you (and your partner, where relevant) during treatment and for a period after stopping.
12. Important interactions with other medicines
Interactions can be caused by changes in how the body metabolises drugs and by overlapping risks (especially blood count suppression).
Always inform your clinician and pharmacist about:
- Medicines that suppress bone marrow (other chemotherapy drugs, some immunosuppressants)
- Other drugs affecting infection risk
- Strong enzyme inducers or inhibitors that may alter metabolism (your pharmacist can check specifics)
- Herbal remedies and supplements (e.g., St John’s Wort)
If you are unsure whether a medicine is safe, ask your pharmacist before taking it.
13. Alternative treatment options (discuss with your clinician)
Alternative options depend heavily on the exact diagnosis, disease stage, previous treatments, and genetic markers. For CLL and other lymphoid malignancies, alternatives may include:
- Targeted therapies: Examples may include BTK inhibitors or BCL-2 inhibitors (choice depends on patient factors and local guidance).
- Immunotherapy: Certain monoclonal antibody treatments may be used alone or with other agents.
- Other chemotherapy regimens: Depending on your health, doctors may select different chemotherapy drugs with differing side effect profiles.
- Watchful waiting / supportive care: Some early-stage situations may be managed with monitoring until treatment is clearly beneficial.
Your oncology team can explain the rationale for choosing Leukeran over other therapies in your specific case.
14. United Kingdom market and legal context
In the UK, cancer medicines are regulated and dispensed under the Medicines and Healthcare products Regulatory Agency (MHRA) medicines framework. Leukeran (chlorambucil) is an established chemotherapy product and is supplied through appropriate healthcare channels in accordance with UK medicines legislation and prescribing practices.
Availability: Availability can vary by supplier and may be influenced by manufacturing supply, demand, and clinical guidelines.
Safety governance: UK healthcare providers follow strict protocols for chemotherapy supply, storage, handling, and patient monitoring.
15. Recent guidance and clinical considerations (UK-focused)
Clinical practice in CLL and related blood cancers continues to evolve. In recent years, UK and international guidance has increasingly incorporated targeted therapies for many patients because they can offer improved effectiveness for certain groups.
However, chlorambucil remains relevant in selected cases, especially for:
- Patients where tolerability, comorbidities, or treatment goals make older regimens suitable
- Situations where alternative agents are not appropriate or are not suitable due to patient factors
- Older or less fit patients, where specialists may choose a less intensive regimen
What this means for you: Your treatment plan should be explained clearly by your specialist team, including why Leukeran is chosen and what alternatives have been considered.
16. Delivery and availability (UK online pharmacy information)
When supplied by an online pharmacy in the UK, chemotherapy medicines are typically dispatched in line with legal requirements and patient safety procedures.
- Order processing: Some items require additional checks, so orders may take longer to dispatch.
- Packaging: Medicines should arrive in safe, tamper-evident packaging. Follow any instructions for safe handling.
- Delivery times: Delivery dates vary by location and carrier. Plan ahead so you do not run out during cycles.
- Contact us: If you have not received your order within the expected timeframe, contact customer support promptly.
Storage at home: Keep tablets in a cool, dry place away from children. Follow the packaging instructions exactly.
17. FAQ – Frequently asked questions
Is Leukeran used for all cancers?
No. Leukeran is used for specific blood cancers and related conditions. The choice depends on diagnosis and treatment strategy decided by specialist teams.
How long does treatment with Leukeran last?
Treatment duration varies. Some regimens are given over cycles with planned monitoring. Your clinician will determine the length based on response and blood counts.
What blood tests will I need?
Typically, you will have regular blood tests such as a full blood count (FBC) to monitor white blood cells, haemoglobin, and platelets. Your team may also check other tests depending on your situation.
What side effects are most common?
Common side effects can include fatigue, nausea, and changes in blood counts. The severity varies by dose, schedule, and individual factors.
When should I contact my doctor urgently?
Contact urgent medical services or your oncology team right away for fever, suspected serious infection, unusual bleeding, severe breathlessness, or severe allergic symptoms.
Can I take Leukeran with food?
It is generally possible to take it with or without food. If you experience stomach upset, taking it with food may help. Follow your regimen instructions.
Is it safe to drink alcohol during treatment?
Limit alcohol and discuss your situation with your clinical team. Alcohol may worsen tiredness, nausea, and could affect recovery and liver stress.
Can I take other medicines at the same time?
Some medicines can interact with chlorambucil or increase infection/bleeding risk. Always tell your pharmacist and oncology team about everything you take, including over-the-counter and herbal products.
What if I miss a dose?
Do not double up. Contact your healthcare team for advice on the next step.
How should I store Leukeran?
Store tablets in their original packaging, at recommended temperatures, away from children and pets. Keep them dry and protected from moisture.
Are there alternatives to Leukeran?
Yes. Depending on your diagnosis and patient factors, other chemotherapy regimens, immunotherapy, targeted therapies, or monitoring may be considered. Discuss options with your oncology team.
18. When to get more help
If you have questions about how to take Leukeran, managing side effects, or how to reduce infection or bleeding risks, speak to your oncology team or pharmacist. They can provide guidance tailored to your blood test results and overall health.
Disclaimer: This article is for patient information only and does not replace medical advice. Always follow the instructions and monitoring plan provided by your healthcare professionals.

